Spero Therapeutics - SPRO - Stock Price Today (2024)

(Delayed Data from NSDQ)

$1.44 USD

1.44

38,566

+0.02 (1.41%)

Updated Jul 26, 2024 04:00 PM ET

After-Market: $1.44 +0.01 (0.35%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5 3

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

FValue | FGrowth | CMomentum | FVGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (81 out of 251)

Industry: Medical - Biomedical and Genetics

View All Zacks #1 Ranked Stocks

Quote Overview

Stock Activity

Open
1.41
Day Low
1.40
Day High
1.44
52 Wk Low
1.00
52 Wk High
1.89
20 Day Avg Vol
93,496
Market Cap
77.47 M
Dividend
0.00 ( 0.00%)
Beta
0.63

Key Earnings Data

Earnings ESP

Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season.

The technique has proven to be very useful for finding positive surprises. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest.

Visit the Earnings ESP Center

See the Full List of Stocks To Beat Earnings

0.00%
Most Accurate Est
-0.35
Current Qtr Est
-0.35
Current Yr Est
-1.27
Exp Earnings Date

This is an estimated date of earnings release. Neither Zacks Investment Research, Inc. nor its Information Providers can guarantee the accuracy, completeness, timeliness, or correct sequencing of any of the Information on the Web site, including, but not limited to Information originated by Zacks Investment Research, Inc, licensed by Zacks Investment Research, Inc. from Information Providers, or gathered by Zacks Investment Research, Inc. from publicly available sources. There may be delays, omissions, or inaccuracies in the Information.

8/8/24
Prior Year EPS
0.43
Exp EPS Growth (3-5yr)

NA

Forward PE
NA
PEG Ratio
NA

Medical»Medical - Biomedical and Genetics

Research Report for SPRO

Snapshot

All Zacks’ Analyst Reports »

News for SPRO

  • Zacks News
  • Earnings
  • Other News

Spero Therapeutics - SPRO - Stock Price Today (3)

Spero Therapeutics - SPRO - Stock Price Today (4)

Spero Therapeutics - SPRO - Stock Price Today (5)

Spero Therapeutics - SPRO - Stock Price Today (2024)

FAQs

What is the price prediction for SPRO? ›

The Wall Street analyst predicted that Spero Therapeutics's share price could reach $7.00 by May 16, 2025. The average Spero Therapeutics stock price prediction forecasts a potential upside of 407.25% from the current SPRO share price of $1.38.

What is the stock market forecast for SPRO? ›

SPRO Stock 12 Month Forecast

Based on 2 Wall Street analysts offering 12 month price targets for Spero Therapeutics in the last 3 months. The average price target is $7.00 with a high forecast of $7.00 and a low forecast of $7.00.

What is the stock price forecast for gthx? ›

Average Price Target

Based on 4 Wall Street analysts offering 12 month price targets for G1 Therapeutics in the last 3 months. The average price target is $5.67 with a high forecast of $8.00 and a low forecast of $3.00. The average price target represents a 45.01% change from the last price of $3.91.

What is the stock price forecast for OTLK? ›

Stock Price Target
High$53.00
Low$25.00
Average$37.43
Current Price$8.52

What is the price target for Spero Therapeutics? ›

According to the 2 analysts' twelve-month price targets for Spero Therapeutics, the average price target is $7.00. The highest price target for SPRO is $7.00, while the lowest price target for SPRO is $7.00. The average price target represents a forecasted upside of 401.79% from the current price of $1.40.

What is the price prediction for the renq in 2025? ›

Based on Renq Finance's historical price performance prediction model, the price of Renq Finance is projected to reach $0.004253 in 2025.

What is the pay stock price forecast? ›

The average price target is $20.90 with a high forecast of $23.00 and a low forecast of $16.00. The average price target represents a 5.08% change from the last price of $19.89.

What is the target stock price forecast? ›

Based on short-term price targets offered by 30 analysts, the average price target for Target comes to $174.43. The forecasts range from a low of $116.00 to a high of $210.00. The average price target represents an increase of 19.24% from the last closing price of $146.29.

What is a share price forecast? ›

A price target is an analyst's projection of a security's future price, one at which an analyst believes a stock is fairly valued. Analysts consider numerous fundamental and technical factors to arrive at a price target.

Why did GTHX stock drop? ›

G1 Therapeutics (GTHX) stock is dropping Monday on a failed Phase 3 clinical trial. The company's trilaciclib trial will wind down after missing its primary endpoint. The company also provided an updated guidance for 2024 today.

What is the stock prediction for G1 Therapeutics in 2025? ›

G1 Therapeutics Stock Prediction 2025

The G1 Therapeutics stock prediction for 2025 is currently $ 3.36, assuming that G1 Therapeutics shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a -11.03% increase in the GTHX stock price.

Is G1 Therapeutics a buy or sell? ›

G1 Therapeutics stock has received a consensus rating of buy. The average rating score is and is based on 32 buy ratings, 1 hold ratings, and 0 sell ratings.

What is the price target for Therapeutics stock? ›

The average price target for TG Therapeutics is $28.00. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $49.00 ,the lowest forecast is $7.00.

What is the stock price forecast for OTLK in 2025? ›

$38.24 ↑358.46% Estimated share price by July 24, 2025.

Is Outlook Therapeutics a buy or sell? ›

Outlook Therapeutics's analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.

What is the price prediction for flare in 2024? ›

The forecasted Flare price at the end of 2024 is $0.0512 - and the year to year change +189%. The rise from today to year-end: +92%.

What is the price prediction for Req in 2025? ›

Long-term Request Network price prediction for 2025, 2026, 2027, 2028, 2029 and 2030
YearYearly LowYearly High
2025$ 0.086207$ 0.276065
2026$ 0.094558$ 0.161129
2027$ 0.091006$ 0.105884
2028$ 0.091074$ 0.121608
2 more rows

What is the price prediction for the graph coin in 2025? ›

The Graph (GRT) Price Prediction 2030
YearPrice
2024$ 0.198698
2025$ 0.208633
2026$ 0.219065
2027$ 0.230018
1 more row

What is the price prediction for Argo Blockchain? ›

The average price target for Argo Blockchain is $1.07. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $1.20 ,the lowest forecast is $1.00. The average price target represents -37.24% Decrease from the current price of $1.705.

References

Top Articles
Latest Posts
Article information

Author: Aron Pacocha

Last Updated:

Views: 6425

Rating: 4.8 / 5 (48 voted)

Reviews: 87% of readers found this page helpful

Author information

Name: Aron Pacocha

Birthday: 1999-08-12

Address: 3808 Moen Corner, Gorczanyport, FL 67364-2074

Phone: +393457723392

Job: Retail Consultant

Hobby: Jewelry making, Cooking, Gaming, Reading, Juggling, Cabaret, Origami

Introduction: My name is Aron Pacocha, I am a happy, tasty, innocent, proud, talented, courageous, magnificent person who loves writing and wants to share my knowledge and understanding with you.